Provider review
Harper Meds review
The flat-price promise is real; the month it is priced in is four weeks long.
Both plans say the price does not change with the dose, without hedging, and that holds. What does not hold is the unit — the same sentence sells four weeks of medication, so the charge recurs thirteen times a year rather than twelve and the annual total lands above what the monthly label suggests.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Harper Meds
$149/mo sema · $196/mo tirz, flat at every dose
FDA warning letter · Harper Meds · June 2026 · addressed to Nexus Health Solutions LLC dba Harper Meds. Details in our review.
- Vs median
- $20/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Harper makes the promise this site exists to check, and it makes it cleanly: same price at every dose, no increases, with the consultation, the prescription, the medication and the shipping folded into one figure. For someone intending to hold at a low dose that is the right structure, because the dose becomes a clinical decision rather than a budgeting one. Read the unit before you budget, though. The plan is sold as a month and delivers four weeks, which is a thirteenth charge nobody plans for and roughly an extra eight percent on the year. That is not hidden — it is written on the same card as the price — but it is written in a way most readers will slide past. The other limit is that the flat rate is a floor rather than a ceiling: both plans read "From", and no second rung is published to show what sits above. And no pharmacy is named, so you cannot check who compounds the drug until after you have committed.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are holding at a low dose and want a price that will not move when your dose does.
- You want the consultation, the prescription and shipping inside one figure rather than itemized later.
- You would rather not be charged at all if a doctor declines to prescribe — payment is held until approval.
Look elsewhere if
- You are budgeting by the calendar. The cycle is four weeks, so the year holds thirteen charges, not twelve.
- You want to know who compounds your medication before you order. No pharmacy is named.
- You need to know the ceiling. Both plans are quoted "From", with no upper rung published.
What it actually costs
Price as published
Compounded semaglutide from $149/month · compounded tirzepatide from $196/month · both sold as "ONE PRICE for everything: doctor consultation, prescription, 4 weeks of medication & free shipping" with "Same price for ALL doses — no price increases" · the billing unit is FOUR WEEKS, not a calendar month — at 13 cycles a year the semaglutide plan costs about $1,937 rather than the $1,788 that "$149/month" implies, roughly 8.3% more, and the tirzepatide plan about $2,548 rather than $2,352 · payment is authorized at checkout but held until a doctor approves the prescription
- Vs median
- $20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. Both plans state flatly that the price does not change with the dose, so a patient holding at a quarter dose pays what a patient at a full dose pays. That cuts both ways and the site says so honestly: there is no penalty for titrating up, and no saving for staying low. The economics that actually matter here are in the billing unit rather than the dose — the recurring charge covers four weeks, not a calendar month, so the plan bills thirteen times in a year and the true annual cost sits meaningfully above the figure the monthly label suggests.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- Flat pricing at every dose, stated without qualification — "Same price for ALL doses — no price increases" — so holding at a quarter dose is not penalized and moving up is not punished
- One figure covers the consultation, the prescription, the medication and shipping, with no membership or separate visit fee layered on top
- Both molecules carry a published rate at the point of selection rather than hiding the price behind an intake quiz
- Payment is authorized but held at checkout until a doctor approves the prescription, so an unapproved patient is not charged and left to chase a refund
Pharmacy, labs and oversight
Harper Meds dispenses through a Not named — "our partner pharmacy" facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Harper Meds publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Harper Meds in June 2026. It is addressed to Nexus Health Solutions LLC dba Harper Meds — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Harper Meds is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Harper Meds sells compounded semaglutide and compounded tirzepatide as a single all-inclusive subscription per molecule: the consultation, the prescription, the medication and shipping are bundled into one recurring figure, and that figure does not move as the dose goes up. The flat-price claim is stated plainly and without qualification — "Same price for ALL doses — no price increases" — which makes it the rare pricing promise a low-dose patient can actually rely on. The catch is not in the promise but in the unit: the same sentence that bundles everything also says the plan covers four weeks of medication, so the "month" being priced is a 28-day cycle that recurs thirteen times a year. Prescriptions ship from an unnamed partner pharmacy after a doctor reviews an online intake.
The honest cons
THE MONTH IS FOUR WEEKS. "From $149/month" buys "4 weeks of medication", which recurs 13 times a year rather than 12 — about $1,937 a year on semaglutide against the $1,788 the headline implies, and about $2,548 against $2,352 on tirzepatide
- The flat price is a floor — both plans read "From", and no second rung is published to show what, if anything, sits above it
- No pharmacy is named; the site refers only to "our partner pharmacy", so a patient cannot check who compounds the drug before ordering
- No LegitScript seal is displayed
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Harper Meds is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#161 of 373
Ordered with the companies that pay us first, and Harper Meds is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.